首页> 外国专利> Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor

Transcriptional co-repressor that interacts with nuclear hormone receptors and uses therefor

机译:与核激素受体相互作用的转录共阻遏物,并为此而使用

摘要

In accordance with the present invention, there are provide novel receptor interacting factors, referred to herein as “SMRT”, i.e., a silencing mediator (co-repressor) for retinoic acid receptor (RAR) and thyroid hormone receptor (TR). SMRT is a novel protein whose association with RAR and TR both in solution and on DNA response elements is destabilized by ligand. The interaction of SMRT with mutant receptors correlates with the transcriptional silencing activities of receptors. In vivo, SMRT functions as a potent co-repressor. A GAL4 DNA binding domain (DBD) fusion of SMRT behaves as a frank repressor of a GAL4-dependent reporter. Together, these data identify a novel class of cofactor which is believed to represent an important mediator of hormone action.
机译:根据本发明,提供了新颖的受体相互作用因子,在本文中称为“ SMRT”,即视黄酸受体(RAR)和甲状腺激素受体(TR)的沉默介体(共阻遏剂)。 SMRT是一种新型蛋白质,其在溶液中和在DNA反应元件上与RAR和TR的结合都被配体破坏了稳定性。 SMRT与突变受体的相互作用与受体的转录沉默活性有关。在体内,SMRT充当有效的共阻遏物。 SMRT的GAL4 DNA结合域(DBD)融合体表现为依赖GAL4的报告基因的坦率阻遏物。这些数据共同确定了新型的辅因子,据信它代表着激素作用的重要介体。

著录项

  • 公开/公告号US7270955B2

    专利类型

  • 公开/公告日2007-09-18

    原文格式PDF

  • 申请/专利权人 RONALD M. EVANS;J. DON CHEN;

    申请/专利号US20030351750

  • 发明设计人 RONALD M. EVANS;J. DON CHEN;

    申请日2003-01-23

  • 分类号C12Q1/68;G01N33/567;C12N15/36;

  • 国家 US

  • 入库时间 2022-08-21 21:03:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号